A new statement from leading heart and blood vessel experts in Europe is providing clinical guidance for treatments to prevent blood clots in patients with a serious condition called chronic limb-threatening ischaemia (CLTI), after they have had procedures to restore blood flow in their lower limbs. The statement, and the systematic review it is based on, comes from the European Society of Cardiology (ESC) Working Group on Aorta and Peripheral Vascular Diseases and Working Group on Cardiovascular Pharmacotherapy. 

Heading a soccer ball alters the brain, new research spearheaded by the University of Sydney has found, despite having no immediate impact on cognition.  

Researchers have found that the anti-aging drug Rapamycin extends lifespan as effectively as eating less.

Dietary restriction has long been considered one of the most reliable methods for increasing lifespan across species. But if fasting for hours sounds unpleasant, science may suggest another route to achieving a longer and healthier life.

A new study reveals that Rapamycin, a compound originally developed as an immunosuppressant, offers comparable life-extending benefits in eight species of vertebrates (not including humans). 

In this, the largest study of its kind, the team investigated the effect of Rapamycin and Metformin on longevity - both of which have been touted as life-extending drugs.

They found that Rapamycin extends lifespan almost as consistently as eating less, while the Type 2 diabetes medicine, Metformin, does not.